Page last updated: 2024-08-25

rosiglitazone and Graft vs Host Disease

rosiglitazone has been researched along with Graft vs Host Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jang, KY; Jeon, SY; Kim, HS; Kwak, JY; Lee, NR; Park, HS; Rho, HW; Sohn, MH; Song, EK; Song, MY; Yhim, HY; Yim, CY; Yim, JM; Yim, JY; Yim, SK	1

Other Studies

1 other study(ies) available for rosiglitazone and Graft vs Host Disease

Article	Year
Rosiglitazone prevents graft-versus-host disease (GVHD). Transplant immunology, 2012, Volume: 27, Issue:2-3 Topics: Animals; Antigens, CD; Cells, Cultured; Cytokines; Disease Models, Animal; Gene Expression Regulation; Graft vs Host Disease; Histocompatibility; Humans; Immunophenotyping; Isoantigens; Lymphocyte Culture Test, Mixed; Lymphocyte Subsets; Lymphocytes; Membrane Proteins; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; NF-kappa B; PPAR gamma; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Receptors, Neurokinin-1; Rosiglitazone; Thiazolidinediones	2012

Article

Year

Rosiglitazone prevents graft-versus-host disease (GVHD).

Transplant immunology, 2012, Volume: 27, Issue:2-3

Topics: Animals; Antigens, CD; Cells, Cultured; Cytokines; Disease Models, Animal; Gene Expression Regulation; Graft vs Host Disease; Histocompatibility; Humans; Immunophenotyping; Isoantigens; Lymphocyte Culture Test, Mixed; Lymphocyte Subsets; Lymphocytes; Membrane Proteins; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; NF-kappa B; PPAR gamma; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Receptors, Neurokinin-1; Rosiglitazone; Thiazolidinediones

2012